Form 4: ARYA Sciences Holdings IV Distributes Adagio Medical Holdings Shares to Shareholders

ARYA Sciences Holdings IV executed a pro rata distribution of Adagio Medical Holdings common stock to its shareholders on September 27, 2024.

Summary

• On September 27, 2024, ARYA Sciences Holdings IV (the 'Sponsor') distributed shares of Adagio Medical Holdings, Inc. common stock to its shareholders.
• The distribution was pro rata and for no consideration.
• The distributed shares included 1,147,500 shares subject to share price trigger vesting ('Earn-Out Shares').
• These Earn-Out Shares will vest if Adagio Medical Holdings' share price equals or exceeds $24.00 for any 20 trading days within any 30 trading day period before the tenth anniversary of the business combination closing.
• If the vesting condition is not met within the Earn-Out Period, the Earn-Out Shares will be forfeited and cancelled.
• The Sponsor directly held the reported securities.
• Adam Stone and Michael Altman, as directors of the Sponsor, have voting and investment discretion over the shares and may be deemed to have shared beneficial ownership.

Sentiment

Score: 6

Explanation: The document itself is neutral, reporting a standard distribution of shares. The potential for Earn-Out Shares to vest adds a slightly positive element, but it's contingent on future performance.

Positives

• The distribution of shares could be seen as a positive for ARYA Sciences Holdings IV shareholders, providing them with direct ownership in Adagio Medical Holdings.
• The Earn-Out Shares provide an incentive for Adagio Medical Holdings to increase its share price, potentially benefiting all shareholders.

Negatives

• If Adagio Medical Holdings' share price does not reach $24.00 within the Earn-Out Period, the 1,147,500 Earn-Out Shares will be forfeited, which could be perceived negatively.

Risks

• The vesting of the Earn-Out Shares is contingent on Adagio Medical Holdings' share price performance, which is subject to market risks and company-specific factors.
• Failure to meet the vesting condition could lead to the forfeiture of a significant number of shares.

Future Outlook

The future vesting of the Earn-Out Shares depends on Adagio Medical Holdings' share price reaching $24.00 within the Earn-Out Period.

Industry Context

Distribution of shares to shareholders is a common practice after a business combination, allowing original investors to directly participate in the performance of the acquired company. The use of earn-out provisions tied to share price performance is also a common mechanism to align the interests of the original investors with the long-term success of the company.

Comparison to Industry Standards

• The distribution of shares following a business combination is a standard practice, similar to distributions seen after SPAC mergers where sponsor shares are distributed to their investors.
• Earn-out provisions tied to stock performance are also common, with the specific targets (e.g., $24.00 share price) and timeframes (e.g., 10-year earn-out period) being deal-specific and reflecting the negotiated terms between the parties.

Stakeholder Impact

• Shareholders of ARYA Sciences Holdings IV now directly own shares of Adagio Medical Holdings.
• The potential vesting of Earn-Out Shares could benefit all Adagio Medical Holdings shareholders if the share price increases.

Key Dates